Catalyzing Precision Medicine Through Prospective, High-Throughput Characterization of Cancer Variants 2019 ASPIRE II Award William C. Hahn, MD, PhD (Principal), Broad Institute and Dana-Farber Cancer Institute; James Neal, PhD, Broad Institute Read More
Machine Learning to Predict the Progression of Cancer and Treatment Effectiveness 2019 ASPIRE II Award David Sontag, PhD, Massachusetts Institute of Technology Read More
TargetAlloMod, a Proprietary Drug Discovery Platform for Immuno-oncology 2019 Drug Discovery Award Evotec Read More
Rational Design of Novel Combination Immunotherapies: Enhancing the Cytotoxic Activity of Chimeric Antigen Receptor T Cells 2019 ASPIRE Award Marco Ruella, MD (Principal); Sara Cherry, PhD; and Igor Brodsky, PhD, University of Pennsylvania Read More
Target Class Approach to Develop DUB Inhibitors 2019 ASPIRE Award; 2021 ASPIRE II Award Sara Buhrlage, PhD (Principal) and Jarrod Marto, PhD, Dana-Farber Cancer Institute Read More
Engineering TGF-β-resistant, Tri-Specific T-Cell Therapy for Glioblastoma Multiforme 2019 Emerging Leader Award Yvonne Y. Chen, PhD, University of California, Los Angeles Read More
